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The link between changes in a subjectʼs metabolic syndrome components and his estimated glomerular 
ﬁltration rate (eGFR) was evaluated in healthy Japanese men.  We used data from 120 Japanese men 
(45.5±8.4 years) with a 1-year follow up.  eGFR was deﬁned by a new equation developed for Japan.  
There were no signiﬁcant diﬀerences in eGFR between men with and without metabolic syndrome 
components at baseline.  Subjects were given advice for dietary and lifestyle improvement.  At the 
1-year follow up,  almost all metabolic syndrome components were signiﬁcantly improved.  However,  
eGFR was signiﬁcantly decreased.  The changes in eGFR were weakly correlated with abdominal cir-
cumference (r＝－0.232,  p＝0.0106).  A decrease in abdominal circumference may be associated with 
improving eGFR in Japanese men.
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hronic kidney disease (CKD) has become a 
public health challenge and is a common disor-
der [1].  For example,  approximately 20ｵ of adults 
have CKD,  which is deﬁned as kidney damage or a 
glomerular ﬁltration rate (GFR) ＜60ml/min/1.73m2 
for at least 3 months,  regardless of cause [2].  We 
have also previously reported in a cross-sectional 
study that the estimated glomerular ﬁltration rate 
(eGFR) [3] in men with abdominal obesity and in 
women with hypertension was signiﬁcantly lower than 
that in subjects without these components of metabolic 
syndrome [4].  In addition,  we have shown that 
decreasing systolic blood pressure is associated with 
improving eGFR with lifestyle modiﬁcation in healthy 
Japanese women [5].  However,  whether decreases in 
metabolic syndrome components are beneﬁcial for 
improving eGFR,  and what eﬀect this has on eGFR 
remain to be investigated in a longitudinal study in 
Japanese men.
　 In this study,  we evaluated the link between 
changes in eGFR and changes in metabolic syndrome 
components in Japanese men with a 1-year follow up.
Subjects and Methods
　 Subjects. We used data for 120 Japanese men 
from a data-base of 16,383 people at the Okayama 
Southern Institute of Health in Okayama prefecture,  
Japan,  aged 45.5±8.4 years,  who met the following 
criteria: (1) received a health check-up,  including 
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special health guidance and a follow-up check-up 
1-year later; (2) received anthropometric measure-
ments,  fasting blood examination,  and blood pressure 
measurements as part of the annual health check-
up; (3) received no medications for diabetes,  hyper-
tension,  and/or dyslipidemia; and (4) provided written 
informed consent (Table 1).
　 At the ﬁrst health check-up,  all subjects were 
given instructions by well-trained medical staﬀ on how 
to change their lifestyle as special health guidance.  
Nutritional instruction was provided with a well-
trained nutritionist,  who planned a diet for each sub-
ject based on their data and provided simple instruc-
tions (i.e.  not to eat too much and to consider balance 
when they eat).  Exercise instruction was also pro-
vided by a well-trained physical therapist,  who 
encouraged each subject to increase their daily number 
of steps walked.
　 Ethical approval for the study was obtained from 
the Ethical Committee of the Okayama Health 
Foundation.
　 Anthropometric and body composition mea-
surements. Anthropometric and body composi-
tions were evaluated based on the following 
parameters: height,  body weight,  and abdominal cir-
cumference.  Body mass index (BMI) was calculated by 
weight / [height]2,  in kg/m2.  Abdominal circumfer-
ence was measured at the umbilical level in standing 
subjects after normal expiration [6].
　 Blood pressure measurements at rest.
Resting systolic and diastolic blood pressures were 
measured indirectly using a mercury sphygmomanom-
eter placed on the right arm of the seated participant 
after at least 15 min of rest.
　 Urine examination. Urine samples were col-
lected from the second-morning urine (before 10 a.m. ) 
and subjected to examination within 1h.  The urine 
examination was performed using urine test strips 
(BAYER,  Tokyo,  Japan).  The reagent strip was 
dipped directly into the urine sample.  Just after dip-
ping,  the sample was graded as －: negative,  ±: trace 
positive,  ＋: positive (30mg/dl),  2＋: positive 
(100mg/dl),  3＋: positive (300mg/dl),  or 4＋: posi-
tive (1,000mg/dl) by comparison with a standard color 
chart found on the containerʼs label.
　 Blood sampling and assays. We measured 
overnight fasting serum levels of creatinine (Cr) 
(enzymatic method),  high-density lipoprotein (HDL) 
cholesterol,  triglycerides (L Type Wako Triglyceride・
H,  Wako Chemical,  Osaka,  Japan),  and blood sugar.  
eGFR was calculated using the following equation:  
eGFR (ml/min/1.73m2)＝194×Cr－1.094×Age－0.287 
[3].  Reduced eGFR was deﬁned as an eGFR 
＜60ml/min/1.73m2.
　 Deﬁnition of metabolic syndrome. Men with 
an abdominal circumference in excess of 85cm were 
deﬁned as having metabolic syndrome if they also had 
two or more of the following components: 1) 
Dyslipidemia: triglyceridesｧ150mg/dl and/or HDL 
cholesterol＜40mg/dl,  2) High blood pressure: blood 
pressureｧ130/85mmHg,  3) Impaired glucose 
tolerance: fasting plasma glucoseｧ110mg/dl [6].
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Table 1　 Clinical characteristics and changes in parameters with 1-year follow up
Baseline Follow up p
Number of Subjects 120
Age 45.5±8.4
Height (cm) 169.0±5.3
Body weight (kg) 75.6±11.3 74.0±10.7 ＜0.0001
Body mass index (kg/m2) 26.5±3.6 25.9±3.4 ＜0.0001
Abdominal circumference (cm) 88.5±9.8 86.3±9.2 ＜0.0001
Systolic blood pressre (mmHg) 131.5±14.6 123.9±12.5 ＜0.0001
Diastolic blood pressure (mmHg) 82.6±11.5 77.0±9.2 ＜0.0001
Triglyceride (mg/dl) 153.3±110.2 121.7±80.3 0.0011
HDL cholesterol (mg/dl) 54.2±14.6 56.2±14.9 0.0390
Blood sugar (mg/dl) 102.7±18.1 104.2±28.3 0.3710
Cr (mg/dl) 0.81±0.12 0.84±0.12 0.0012
eGFR (ml/min/1.73m2) 84.0±13.9 80.1±13.1 ＜0.0001
Mean±SD
　 Statistical analysis. Data are expressed as 
means ± standard deviation (SD).  A statistical analy-
sis was performed using a paired t test and χ2 test:  
p＜0.05 was considered to be statistically signiﬁcant.  
Pearsonʼs correlation coeﬃcients were calculated and 
used to test the signiﬁcance of the linear relationship 
among continuous variables.
Results
　 The clinical parameters at the baseline and the 
1-year follow up are summarized in Table 1.  Anthro-
pometric and body composition parameters such as 
body weight,  BMI,  and abdominal circumference were 
signiﬁcantly reduced with lifestyle modiﬁcation after 
1 year.  Cr was signiﬁcantly increased,  and eGFR was 
decreased.  Thirty-six subjects were diagnosed as hav-
ing metabolic syndrome at baseline,  and 18 subjects 
were diagnosed as having metabolic syndrome after 1 
year,  which was a signiﬁcant reduction (p＜0.0001).  
Two subjects were diagnosed with reduced eGFR at 
baseline,  and 3 subjects were diagnosed with reduced 
eGFR at the 1-year follow up.  In addition,  four sub-
jects were identiﬁed as trace positive,  2 were identi-
ﬁed as positive (＋),  and one was identiﬁed as positive 
(2＋) for proteinuria at baseline,  while 5 were identi-
ﬁed as trace positive,  4 as positive (＋),  and 2 as 
positive (2＋) at the 1-year follow up.
　 In subjects not taking medications,  we also com-
pared eGFR levels between the groups with and 
without each component of the Japanese deﬁnition of 
metabolic syndrome (Table 2).  eGFR in men with 
abdominal obesity was signiﬁcantly higher than that in 
men without abdominal obesity.  However,  there were 
no signiﬁcant diﬀerences of eGFR between the groups 
with or without other components of metabolic syn-
drome.  In addition,  eGFR in subjects with metabolic 
syndrome was similar to that in subjects without it.
　 We further evaluated the relationship between 
changes in eGFR and changes in clinical parameters.  
Changes in eGFR were weakly correlated with 
changes in abdominal circumference (r＝－0.232,  p＝
0.0106) (Table 3,  Fig.  1).  After we excluded one 
subject with abnormal changes in eGFR (－37.7ml/
min/1.73m2),  changes in eGFR were still weakly cor-
related with changes in abdominal circumference (n＝
119,  r＝－0.203,  p＝0.0265).  However,  changes in 
eGFR were not signiﬁcantly correlated with changes 
in other metabolic components.
　 Finally,  we investigated the changes in eGFR 
amongst men with diﬀerent levels of increased 
abdominal circumference [Group I: Delta (delta rep-
resents positive changes in abdominal circumference) 
abdominal circumference≧0cm,  Group D: Delta 
abdominal circumference＜0cm].  After the 1-year 
follow up,  changes in eGFR in Group I (－6.0±
10.2ml/min/1.73m2) were lower than those in Group 
D (－2.7±8.2ml/min/1.73m2),  but not at a signiﬁcant 
level (p＝0.0599).
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Table 2　 Comparison of eGFR between men with and without metabolic syndrome
Number of subjects
eGFR (ml/min/1.73m2)
Abdominal obesity (－)
42
79.1±13.9
Abdominal obesity (＋)
78
86.6±13.2
p
0.0042
Number of subjects
eGFR (ml/min/1.73m2)
Impaired glucose torelance (－)
96
82.7±13.7
Impaired glucose torelance (＋)
24
88.8±13.8 0.0535
Number of subjects
eGFR (ml/min/1.73m2)
Hypertension (－)
48
83.2±14.8
Hypertension (＋)
72
84.5±13.3 0.6326
Number of subjects
eGFR (ml/min/1.73m2)
Dyslipidemia (－)
71
82.3±14.1
Dyslipidemia (＋)
49
86.2±13.5 0.1348
Number of subjects
eGFR (ml/min/1.73m2)
Metabolic syndrome (－)
84
82.4±14.0
Metabolic syndrome (＋)
36
87.5±13.2 0.0644
Mean±SD
Discussion
　 The main objective of this study was to explore the 
link between changes in eGFR and changes in meta-
bolic syndrome components in Japanese men with a 
1-year follow up.
　 Ninomiya T et al. [7],  Tanaka et al. [8] and Iseki 
et al. [9] reported that metabolic syndrome,  using the 
modiﬁed ATP III deﬁnition [10],  was associated with 
CKD in the Japanese population.  Compared with 
subjects with 0 or 1 components of metabolic syn-
drome,  subjects with 2,  3,  and 4 or more components 
had odds ratios of 1.13,  1.90,  and 2.79 for CKD [7].  
In this study,  36 subjects was diagnosed as having 
metabolic syndrome,  using the Japanese criteria,  at 
baseline,  and 18 were diagnosed as having metabolic 
syndrome at the 1-year follow up.  We have previously 
reported a prevalence of 30.7ｵ for metabolic syn-
drome in Japanese men [11].  In this study,  with 
lifestyle modiﬁcation after the initial health check-up,  
metabolic components were signiﬁcantly improved in 
men without medications at the 1-year follow-up.  
Although eGFR was not increased after 1 year,  
changes in eGFR were negatively correlated with 
changes in abdominal circumference.  Taken together,  
lifestyle modiﬁcation targeting reducing abdominal 
circumference may be a useful method for improving 
eGFR in Japanese men.
　 Abdominal obesity contributes to the development 
of renal injury and end-stage renal disease [12-14].  
Bonnet et al. have reported that abdominal obesity is 
related to the development of elevated albuminuria in 
both sexes,  suggesting that the measurement of 
abdominal circumference might improve the identiﬁca-
tion of non-diabetic individuals at risk of developing 
microalbuminuria [12].  In addition,  a greater waist-
to-hip ratio is associated with a greater risk of dimin-
ished ﬁltration,  even when corrected for BMI [13].  
Yamagata et al. have reported that the baseline-
adjusted predictor of developing CKD included age,  
GFR,  hematuria,  hypertension,  diabetes,  serum lip-
ids,  obesity,  smoking status,  and consumption of 
alcohol with a 10-year follow up [14].  In the present 
study,  there were signiﬁcant diﬀerences in eGFR 
between subjects with and without abdominal obesity 
at baseline.  However,  we revealed that,  with lifestyle 
modiﬁcation,  changes in abdominal circumference 
were weakly correlated with changes in eGFR in men 
without medications.  Changes in other metabolic 
components were not linked to changes in eGFR.  
Therefore,  the clinical impact of adnominal circum-
ference on eGFR was noted in Japanese men.
　 Potential limitations remain in our study.  First,  
the 16,383 subjects in our study voluntarily underwent 
the annual health check-up; they were,  therefore,  
probably more health-conscious than the average per-
son.  The selected 120 men underwent an annual health 
check-up every year with a follow-up duration of 
1-year and received no medication; they were,  there-
fore,  probably even more health-conscious than most 
of the subjects in the database,  and the small sample 
size may make it diﬃcult to infer causality between 
eGFR and abdominal circumference.  At baseline,  in 
contrast to our previous report regarding a large 
sample (n＝11,711) from a cross-sectional study [4],  
eGFR in men with abdominal obesity was higher than 
that in men without abdominal obesity.  eGFR was not 
increased with lifestyle modiﬁcation after 1 year 
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Fig. 1　 Simple correlation analysis between changes in eGFR 
and changes in systolic blood pressure at the 1-year follow up.
Table 3　 Simple correlation analysis between changes in eGFR 
andchanges in clinical parameters with 1-year follow up
r p
Abdominal circumference (cm) －0.232 0.0106
Systolic blood pressre (mmHg) 0.094 0.3068
Diastolic blood pressure (mmHg) －0.009 0.9227
Triglyceride (mg/dl) －0.055 0.5521
HDL cholesterol (mg/dl) －0.016 0.8616
Blood sugar (mg/dl) －0.030 0.7458
(－3.9ml/min/1.73m2/year).  A link has previously 
been found between eGFR and age,  based on a large 
sample from a Japanese cohort,  with an average 
decline rate of eGFR of 0.36ml/min/1.73m2/year 
[15].  Therefore,  the decline rate of eGFR in our 
study was higher than that previously reported.  
Second,  we could not identify the mechanism of the 
linkage between eGFR and abdominal circumference.  
Third,  most of the enrolled subjects were not diag-
nosed as CKD at baseline.  Therefore,  the results in 
this study may not apply to patients with CKD.  
Further prospective studies are needed in Japanese 
subjects.
　 In conclusion,  a decrease in abdominal circumfer-
ence with lifestyle modiﬁcation might induce an 
improvement in eGFR.  Therefore,  lifestyle modiﬁca-
tion may be a necessary and useful measure for the 
prevention of CKD in Japanese men.
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